Tardis

Tardis represents a moderate-potency cannabis option featuring a diverse cannabinoid composition with scientifically studied potential benefits. The strain delivers a sophisticated flavor and scent profile rooted in terpenes recognized for their capacity to manage discomfort and worry while maintaining mental clarity and drive. When used appropriately, Tardis may support users in maintaining focus and composure as they work through their daily responsibilities in an organized manner.

The sativa-dominant genetics are moderated by lesser-studied cannabinoids present consistently in this strain's chemical makeup. CBC offers substantial anti-inflammatory effects and stress relief capabilities that research suggests surpass CBD's efficacy by several times over. CBG provides anti-inflammatory action alongside mood elevation, supporting neural and skeletal development, plus evidence suggests it may inhibit tumor growth. THCV functions to prevent and diminish anxiety episodes and involuntary muscle movements, with research indicating potential to reduce neurological damage and encourage bone formation. The aromatic compounds contributing to Tardis's unique profile—including beta-myrcene, caryophyllene, limonene, linalool, and azulene—support relaxation and anxiety reduction. Beta-myrcene, caryophyllene, and limonene additionally demonstrate research-backed potential as anti-cancer agents.